Replies to post #2354 on Radient Pharmaceuticals Corporation fka RXPC

[primarywatcher]

Rainmaker comments current O/S here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59228557

IMO, as for:
1) it's not clear at all about the two spinoffs being traded publically, so I can't comment there.

2) they're in the habit here of increasing shares. Check out proxy statements here: http://www.dailyfinance.com/company/radient-pharmaceuticals-corporation/rpc/ase/sec-filings

3) they can "seriously" commercialize their "multiple" cancer tests outside the US, but can only offer Onko-Sure for colorectal cancer in US. Here is Onko-Sure website, may help give you an idea of the potential: http://www.onko-sure.com/

IMO - This stock is running on fumes because we're awaiting notification of AMEX approval for extension on listing - literally any minute today. (was noted to expect news yesterday w/in 24-48 hrs.) IF the stock is de-listed, shorts will bank - TEMPORARILY. IF extension granted, we could very well shoot above $1.20 (check chart 1/7/11) where this stock tanked after trading halt and notification of approval of new shares on the market.

IMPORTANT TO REMEMBER: News is still pending on a Mayo clinical study, due end of Feb.

I hope others with more knowledge on O/S and float offer greater clarification here.

glty!